Status and phase
Conditions
Treatments
About
HES 130/0.4 significantly solution will not affect on coagulation and blood loss in patients medicated with antiplatelet agents prior to off-pump coronary bypass surgery (OPCAB).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patient who has
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal